Advanced search
Publication Cover
Pathology Volume 31, 1999 - Issue 3
Submit an article Journal homepage
3
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A COMPARISON OF THE PATTERN OF CATHEPSIN-D EXPRESSION IN FIBROADENOMA, FIBROCYSTIC DISEASE, PREINVASIVE AND INVASIVE DUCTAL BREAST CARCINOMA

WEI-QIANG ZHENG, LAI-MENG LOOI, PHAIK-LENG CHEAH Department of Pathology, Faculty of Basic Medicine, Second Military Medical University, Shanghai, China; Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Pages 247-251 | Published online: 06 Jul 2009

  • Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983; 695: 177-214.
  • Rochefort H, Capony F, Garcia M. Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev 1990; 9: 321-31.
  • Westley B, Rochefort H. Estradiol induced proteins in the MCF-7 human breast cancer cell line. Biophys Res Commun 1979; 90: 410-6.
  • Vignon F, Capony F, Chambon M,et al. Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52 k protein. Endocrinology 1986; 118: 1537-45.
  • Takei Y, Higashira H, Yamamoto T, Hayashi K. Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: co-operative role of cathepsin D. Breast Cancer Res Treat 1997; 43: 53-63.
  • Westley B, May FEB, Brown AMC, et al. Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF-7 cells and two tamoxifen-resistant sublines. J Biol Chem 1984; 259: 10030-5.
  • Capony F, Rougeot C, Montcourrier P, et al. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cells. Cancer Res 1989; 49: 3904-9.
  • Rochefort H, Capony F, Garcia M. Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications. Cancer Cells 1990; 2: 383-8.
  • Faust PL, Kornfeld S, Chirgwin JM. Cloning and sequence analysis of cDNA for human cathepsin D. Proc Natl Acad Sci USA 1985; 82: 186-92.
  • Augereau P, Garcia M, Mattel MG, et al. Cloning and sequencing of the 52 kD cathepsin D implementary deoxyribonucleic acid of MCF-R breast cancer cells and mapping on chromosome 11. MoI Endocrinol 1988; 2: 186-92.
  • Rochefort H. Biologial and clinical significance of cathepsin D in breast cancer. Semin Cancer Biol 1990; 1: 153-60.
  • Tandon AK, Clark GM, Chamness GC, et al. Cathepsin D and prognosis in breast cancer. New Engl J Med 1990; 322: 297-302.
  • Fulco RA, Petrix M, Salimbeni V, Torre EA. Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancer. Minerva Med 1998; 89: 5-10.
  • Kute TE, Shao ZM, Sugg NK, et al. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res 1992; 52: 5198-203.
  • Barbi GP, Margallo E, Margiocco M, et al. Evaluation of cathepsin D as prognostic predictor in breast cancer. Oncology 1994; 51: 329-33.
  • Pujol P, Maudelonde T, Daures JP, et al. A propective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer 1993;71:2006-12.
  • Razumovic JJ, Stojkovic RR, Petrovecki M, Gamulin S. Correlation of two methods for determination of cathepsin D in breast carcinoma (immunohistochemistry and ELISA in cytosol). Breast Cancer Res Treat 1997; 43: 117-22.
  • Remmele W, Sauer-Manthey J. Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer. Virchows Arch A Pathol 1993; 422: 467-73.
  • Winstanley JH, Leinster SJ, Cooke TG, et al. Prognostic significance of cathepsin D in patients with breast cancer. Br J Cancer 1993; 67: 767-72.
  • Isola J, Weitz S, Visakorpi T, et al. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol 1993; 11: 36-43.
  • Charpin C, Devictor B, Bonnier P, et al. Cathepsin D immunocytochemical assays in breast carcinomas: Image analysis and correlation to prognostic factors. J Pathol 1993; 170: 463-70.
  • Castiglioni T, Merino MJ, Elsner B, et al. Immunohistochemical analysis of cathepsins D, B and L in human breast cancer. Hum Pathol 1994; 25: 847-8.
  • Joensuu H, Toikkanen S, Isola J. Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 1995; 71: 155-9.
  • Tetu B, Brisson J, Cote C, et al. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study. Int J Cancer 1993; 55: 429-35.
  • O'Donoghue AE, Poller DN, Bell JA, et al. Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat 1995; 33: 137-45.
  • Elston CW. Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987; 300-11.
  • Bolufer P, Torregrosa MD, Gomez L, et al. Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification. Clin Chim Acta 1996; 247: 89-103.
  • Briozzo P, Badet J, Capony F, et al. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991; 194: 252-9.
  • Johnson MD, Torri JA, Lippman ME, Dickson RB. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 1993; 53: 873-7.
  • Ioachim E, Kamina S, Kontostolis M, Agnantis NJ. Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer. Virchows Arch 1997; 431: 311-6.
  • Nadji M, Fresno M, Nassiri M, et at. Cathepsin D in host stromal cells but not in tumor cells, is associated with aggressive behaviour in nodenegative breast cancer. Hum Pathol 1996; 27: 890-5.
  • Losch A, Tempfer C, Kohlberger P, et al. Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer. Br J Cancer 1998; 78: 205-9.
  • Harbeck N, Dettmar P, Thomssen C, et al. Prognostic impact of tumour biological factors on survival in node-negative breast cancer. Anticancer Res 1998; 18: 2187-97.
  • Nikolic-Vukosavljevic D, Grujic-Adanja G, Nastic-Miric D, et al. Cathepsin D: association between TN-stage and steroid receptor status of breast carcinoma. Tumour Biol 1998; 19: 329-34.
  • Gohring UJ, Scharl A, Thelen U, et al. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods. J Clin Pathol 1996; 49: 57-64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.